Literature DB >> 15194312

Impact of steatotic grafts on initial function and prognosis after liver transplantation.

R C Afonso1, W A Saad, O M Parra, R Leitão, B H Ferraz-Neto.   

Abstract

Steatotic grafts are considered a risk factor for dysfunction or even primary nonfunction of liver transplants; grafts with more than 50% fatty infiltration are routinely discarded. This retrospective study evaluated the impact of macrovesicular and microvesicular steatosis on postoperative initial liver function and prognosis by comparing outcomes to nonsteatotic grafts in 48 liver transplantation patients. Fifteen grafts had macrovesicular steatosis, 13 (27.09%) up to 50% fatty infiltration (MG2), and 2 (4.16%) more than 50% (MG3). Thirty-three (69.75%) grafts had no macrovesicular steatosis (MG1). Initial liver function was adequate in 26 (78.78%), 10 (76.93), and 2 (100%) patients, respectively, in subgroups MG1, MG2, and MG3 (P =.892). Thirty-day survival rates were 90.90%, 100%, and 100%, respectively, in subgroups MG1, MG2, and MG3 (P =.606). Twenty-six grafts showed microvesicular steatosis: 18 (37.50%) showed less than 50% fatty infiltration (mG2), and 8 (16.67%) more than 50% (mG3). Twenty-two (45.83%) grafts had no microvesicular steatosis (mG1). Initial liver function was adequate in 16 (72.72%), 16 (88.88%), and 6 (75%) patients, respectively, in subgroups mG1, mG2, and mG3 (P =.547). Thirty-day survival rates were 90.90%, 100%, and 87.5% respectively, in subgroups mG1, mG2, and mG3 (P =.380). In conclusion, macrovesicular and microvesicular steatotic liver grafts displayed adequate initial function, did not compromise survival, and thus should not be routinely discarded.

Entities:  

Mesh:

Year:  2004        PMID: 15194312     DOI: 10.1016/j.transproceed.2004.03.099

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  4 in total

1.  Hepatic steatosis is not always a contraindication for cadaveric liver transplantation.

Authors:  Jan P Deroose; Geert Kazemier; Pieter Zondervan; Jan N M Ijzermans; Herold J Metselaar; Ian P J Alwayn
Journal:  HPB (Oxford)       Date:  2011-04-07       Impact factor: 3.647

Review 2.  Donor Hepatic Steatosis and Outcome After Liver Transplantation: a Systematic Review.

Authors:  Michael J J Chu; Anna J Dare; Anthony R J Phillips; Adam S J R Bartlett
Journal:  J Gastrointest Surg       Date:  2015-04-28       Impact factor: 3.452

3.  Value of Histopathologic Findings of Post-reperfusion Liver Needle Biopsies.

Authors:  B Geramizadeh; M Hassani; K Kazemi; A R Shamsaifar; S A Malek-Hosseini
Journal:  Int J Organ Transplant Med       Date:  2018-11-01

4.  Deep learning quantification of percent steatosis in donor liver biopsy frozen sections.

Authors:  Lulu Sun; Jon N Marsh; Matthew K Matlock; Ling Chen; Joseph P Gaut; Elizabeth M Brunt; S Joshua Swamidass; Ta-Chiang Liu
Journal:  EBioMedicine       Date:  2020-09-24       Impact factor: 8.143

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.